Luo Xiao-Ning, Chen Liang-Si, Zhang Si-Yi, Lu Zhong-Ming, Huang Yan
Department of Otorhinolaryngology-Head and Neck Surgery, Guangdong General Hospital, Guangdong Academy of Medical Science, 106 Zhongshan 2nd Road, Guangzhou, 510080, People's Republic of China.
Radiol Med. 2015 Dec;120(12):1153-69. doi: 10.1007/s11547-015-0547-8. Epub 2015 May 16.
This meta-analysis compared the efficacy of laryngectomy and three larynx-preservation treatments in patients with advanced laryngeal cancer.
Medline, Cochrane, EMBASE and Google Scholar databases were searched (until May 5, 2014) for studies that evaluated total laryngectomy followed by radiation and three larynx-preserving strategies in patients with advanced laryngeal cancer. The outcomes assessed were the 2- to 5-year overall survival (OS), disease-free survival (DFS), and laryngectomy-free survival (LFS) RESULTS: The search identified ten studies which were used for the meta-analysis (N = 2013 patients). The meta-analysis found that among different treatments, RT alone was associated with the highest rate of OS (71.6 %), DFS (57.8 %), and LFS (79.0 %). OS was similar among the following treatments: laryngectomy→RT vs. CT→RT [P = 0.402]; RT+CT vs. RT alone [P = 0.440]; and RT+CT vs CT→RT [P = 0.588]. DFS rate was higher in patients receiving laryngectomy→RT than CT→RT (P = 0.001) and was similar for RT+CT compared with CT→RT (P = 0.590).
These findings suggest that of the larynx-preserving treatments, RT alone was associated with highest rates of OS, DFS, and LFS in patients with locally advanced cancer of the larynx and hypopharynx. Laryngectomy provided a better rate of DFS than CT and RT, but OS were similar across the different larynx-preserving treatments and laryngectomy.
本荟萃分析比较了全喉切除术与三种喉保留治疗方法在晚期喉癌患者中的疗效。
检索了Medline、Cochrane、EMBASE和谷歌学术数据库(截至2014年5月5日),以查找评估晚期喉癌患者全喉切除术后放疗及三种喉保留策略的研究。评估的结果指标为2至5年总生存率(OS)、无病生存率(DFS)和无喉生存率(LFS)。结果:检索到10项研究用于荟萃分析(N = 2013例患者)。荟萃分析发现,在不同治疗方法中,单纯放疗的OS率(71.6%)、DFS率(57.8%)和LFS率(79.0%)最高。以下治疗方法的OS相似:全喉切除术→放疗与化疗→放疗[P = 0.402];放疗+化疗与单纯放疗[P = 0.440];放疗+化疗与化疗→放疗[P = 0.588]。接受全喉切除术→放疗的患者DFS率高于化疗→放疗(P = 0.001),放疗+化疗与化疗→放疗的DFS率相似(P = 0.590)。
这些研究结果表明,在喉保留治疗方法中,单纯放疗在局部晚期喉癌和下咽癌患者中的OS、DFS和LFS率最高。全喉切除术的DFS率优于化疗和放疗,但不同喉保留治疗方法和全喉切除术的OS相似。